Fecal Microbiota Transplantation

FMT Basics - Gut Reset Button

• Definition: Fecal Microbiota Transplantation (FMT): Infusion of fecal suspension from a healthy donor to a recipient's gut.
• Aim: Corrects dysbiosis by restoring a healthy gut microbial community.
• Concept: Acts as a "gut reset button," introducing beneficial microbes to re-establish eubiosis.
• Key Use: Primarily for recurrent Clostridioides difficile infection (rCDI).

⭐ FMT demonstrates high cure rates (often >80-90%) for rCDI unresponsive to standard antibiotic therapies.

Indications for FMT - When to Poo-transplant?

• Recurrent Clostridioides difficile Infection (rCDI): Strongest evidence & primary indication.
  • ≥ 3 episodes of mild-moderate CDI despite standard antibiotic therapy.
  • ≥ 2 episodes of severe CDI (requiring hospitalization or complicated by pseudomembranes/ileus/megacolon).
  • First recurrence of severe CDI unresponsive to standard antibiotics.
  • Fulminant CDI (e.g., hypotension, shock, ileus, megacolon).
• Inflammatory Bowel Disease (IBD): Emerging evidence.
  • Ulcerative Colitis (UC): Active, mild-moderate cases refractory to conventional therapies.
• Other Potential (Investigational) Uses:
  • Irritable Bowel Syndrome (IBS), particularly diarrhea-predominant.
  • Recurrent Hepatic Encephalopathy.
  • Eradication of Multi-Drug Resistant Organisms (MDROs).

⭐ FMT is most strongly recommended for recurrent Clostridioides difficile infection (rCDI) where patients have failed appropriate antibiotic treatments.

FMT Procedure - Donor to Delivery

• Donor Selection & Screening:
  • Healthy adult (18-60 yrs).
  • No recent antibiotics (3 months).
  • Screened for pathogens (stool/serum: HIV, HBV, HCV, C. diff).
• Stool Processing:
  • Fresh (<6 hrs) or frozen (-80°C) stool.
  • Min. 50g stool for 200-500mL suspension (saline/glycerol).
  • Homogenized & filtered.
• Recipient Preparation:
  • Bowel lavage (colonoscopy).
  • Stop antibiotics 24-48 hrs before.
• Administration Routes:
  • Upper GI: NG/NJ, EGD, capsules.
  • Lower GI: Colonoscopy (preferred), enema.

⭐ Colonoscopy is the most common and effective route for recurrent C. difficile infection, delivering to the cecum/right colon.

FMT Mechanism & Outcomes - Healing the Gut

• Mechanism of Action:
  • Restores gut microbial diversity (eubiosis).
  • Competitive exclusion of pathogens (e.g., C. difficile).
  • Modulates host immune response; ↓ inflammation.
  • ↑ Production of beneficial Short-Chain Fatty Acids (SCFAs).
• Clinical Outcomes & Efficacy:
  • Recurrent C. difficile Infection (rCDI): Resolution rates >90%.
  • Investigational: Inflammatory Bowel Disease (IBD) (UC > Crohn's), Irritable Bowel Syndrome (IBS), hepatic encephalopathy, metabolic syndrome.
  • Variable efficacy in other conditions.
• Safety Profile:
  • Generally safe.
  • Common: Mild, transient GI symptoms (bloating, diarrhea, cramping).
  • Rare: Infection transmission (strict donor screening vital), sepsis. Aspiration risk with upper GI delivery.
  • Long-term effects under study.

⭐ For recurrent C. difficile infection (rCDI), FMT offers cure rates often exceeding 90%.

High‑Yield Points - ⚡ Biggest Takeaways

• Fecal Microbiota Transplantation (FMT) is a highly effective therapy for recurrent Clostridioides difficile infection (rCDI), particularly after multiple antibiotic failures.
• It works by restoring normal gut flora and microbial diversity, thereby correcting dysbiosis.
• Administration routes include colonoscopy (most effective), enema, and standardized oral capsules.
• Rigorous donor screening is absolutely essential to prevent pathogen transmission.
• Achieves high rCDI cure rates, typically exceeding 80-90%.
• Emerging investigational uses include Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), and metabolic syndrome.